Skip to Content

Sio Gene Therapies Inc SIOX Stock Quote

| Rating as of

Morningstar‘s Stock Analysis SIOX

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics SIOX

Company Profile SIOX

Business Description

Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis.

Contact
130 West 42nd Street, 26th Floor
New York, NY, 10036
T +1 877 746-4891
Industry Biotechnology
Most Recent Earnings Mar 31, 2022
Fiscal Year End Mar 31, 2023
Stock Type
Employees 12